Activators and Inhibitors of Complement

1. Front Matter

   Pages i-x

   PDF

2. The complement system

   • M. A. McAleer, R. B. Sim

   Pages 1-15

3. The structure of immunoglobulins and their interaction with complement

   • D. R. Burton

   Pages 17-36

4. Non-immunoglobulin activators of the complement system

   • P. W. Taylor

   Pages 37-68

5. Solid phase activators of the alternative pathway of complement and their use in vivo

   • P. D. Cooper

   Pages 69-106

6. Nucleophilic compounds acting on C3 and C4

   • E. Sim, K. E. Parker, A. Jones

   Pages 107-125

7. Effects of Drugs, Venoms and Charged Polymers on the Complement System

   • I. Von Zabern

   Pages 127-165

8. Monoclonal antibodies against the terminal complement components

   • R. Würzner

   Pages 167-180

9. Autoantibodies against complement components and their effects on complement activity

   • M. Loos, J. Alsenz, U. Antes, H.-P. Heinz

   Pages 181-200

10. Use of synthetic peptides in exploring and modifying complement reactivities

    • J. D. Lambris, J. D. Becherer, C. Servis, J. Alsenz

    Pages 201-232

11. Back Matter

    Pages 233-239

    PDF

The complement system is a group of proteins which plays a major role in the processing and removal of microorganisms and tissue breakdown products from the circulation and extracellular spaces. The system is activated by a wide range of targets, and activation leads to the production of opsonins, chemotaxis of granulocytes, cell lysis and other biological activities. Inappropriate overactivation of the system contributes to inflammatory tissue damage in the host, while inadequate activation leads to accumulation of immune complexes and other debris in the circulation, and susceptibility to infection. The biology and biochemistry of the system is now adequately understood, and attempts can be made to manipulate the activation and activities of the system for potential therapeutic purposes.
The reviews in this volume summarise what is known of the ways in which the complement system can be activated, by interaction with antibodies, microorganisms, cell debris, and complex carbohydrates and how the activities and activation of the system have been modified, accidentally or by design, in vitro or in vivo by drugs, venoms, particulate carbohydrates, specific antibodies, synthetic peptides and other reagents.

• antibody
• biochemistry
• biology
• cell
• immunoglobulin
• infection
• protein
• proteins
• research
• tissue

• MRC Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, UK

  Robert B. Sim

Policies and ethics